Still’s Disease is a form of arthritis that is characterized by high spiking fevers and transient salmon-colored rash. Still’s disease was first described in children, but it is now known to occur, much less commonly, in adults (in whom it is referred to as adult-onset Still’s disease). There is commonly swelling of the lymph [...]
|
|||||||
|
A recent research study has shown that when a patient’s first Rheumatoid Arthritis (RA) symptoms occur can have an impact on the severity of the disease. If the disease onset was in winter the outcome was worse six months later when compared to patients whose symptoms began in summer. Furthermore, RA patients that [...] I posted late last year about research that indicated women with rheumatoid arthritis (RA) experienced improvement in their RA symptoms during pregnancy. This research found that the relief was related to the amount of fetal DNA in their blood. The higher the level of fetal DNA, the greater the level of relief. Now there [...] A recent study has determined that rheumatoid arthritis (RA) patients that have prolonged use of drugs such as methotrexate, glucocorticoids and TNF-alpha blockers to control the disease may be protecting their hearts as well. Researchers from the University of Las Palmas de Gran Canaria in Spain studied data from over 4300 RA patients from [...] An ancient Chinese herb that has been used for 2,000 years to treat malaria and reduce fevers is now being tested for use in treating autoimmune diseases like rheumatoid arthritis. The new drug is made from the herb chang shan, from the root of the blue evergreen hydrangea. The active compound in chang [...] Anti-tumor necrosis factor (TNF) drugs are the newest class of therapies used for treating inflammatory diseases, such as Crohn’s disease, psoriasis and rheumatoid arthritis (RA). Our last post discussed the benefits of treating RA with a combination of anti-TNF medication and methotrexate. But there is new research that indicates concern for treating certain individuals [...] The FDA has received 30 reports of cancer in children under the age of 18 who had been treated for JIA with anti-TNF drugs along with other medications, such as methotrexate, or similar immunosuppressant drugs. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
